134 Towards the Effective Protection of LGBTI Persons Deprived of Liberty denying hormone treatment are in place. The interruption of such treatment has severe consequences. Reports show that individuals in needs of gender-reaffirming hormone replacement therapy and life-sustaining HIV/AIDS medications often experience lengthy delays when seeking medical care in immigration detention facilities. Immigration detention facilities, like other places of deprivation of liberty, are considered high-risk environments for STI transmission. This is aggravated when there is limited or no access to prevention commodities such as condoms and lubricants. Access to a doctor also represents a key safeguard against torture and ill-treatment, and seeing healthcare staff upon arrival to an immigration detention facility may be the first opportunity for a migrant can raise an allegation of mistreatment. See Chapter III (6) (“Access to healthcare”) for more guidance on monitoring access to healthcare95. 95 See also APT, IDC, UNHCR, Monitoring immigration detention: Practical manual, pp. 146-156.